Lafora Disease: Clinical Trials

1 trial for Lafora Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Lafora Disease: new trials by email Literature Review of Lafora Disease trials Research Report on Lafora Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease
ION283 - Lafora Disease
Phase 1 / Phase 2RecruitingBerge Minassian102024-12-032025-12-18

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Epilepsies, Myoclonic (1)  ·  Epilepsy (1)  ·  Epilepsy, Generalized (1)  ·  Epileptic Syndromes (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Myoclonic Epilepsies, Progressive (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)

Sponsors

Berge Minassian (1)

Countries

United States (1)

Top investigators

Berge Minassian, MD (1)